Clinical TrialsSearch results
Number of results: 227
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Randomized study comparing six times of epirubicin instillation for 2.5 months with six times for two weeks in superficial bladder cancer after transurethral resection of bladder tumor
- Superficial bladder cancer
- Japanese Urological Cancer Research Group
- 2005-09-30
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06